Ligand Pharmaceuticals (LGND) Work In Process (2023 - 2024)
Ligand Pharmaceuticals' (LGND) quarterly Work In Process came in at $3.9 million in Q4 2024, up 1911.79% year-on-year from $195000.0 in Q1 2024, and up 1408.85% quarter-over-quarter from $260000.0 in Q3 2024.
Ligand Pharmaceuticals (LGND) Work In Process (2023 - 2024) Analysis & Trends
Ligand Pharmaceuticals has disclosed Work In Process across 2 years of filings, most recently posting $3.9 million for Q4 2024.
- Work In Process for Q4 2024 came in at $3.9 million, up 1911.79% year-over-year; the trailing twelve-month figure through Dec 2024 was $3.9 million (up 1911.79% YoY), and the FY2024 annual result was $3.9 million, up 1911.79% from the prior year.
- Work In Process came in at $3.9 million for Q4 2024 at Ligand Pharmaceuticals, up from $260000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $3.9 million in Q4 2024 to a low of $195000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.92 Mn |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 548,000.00 |
| Dec 31, 2023 | 195,000.00 |